A Phase 1b, Randomized, Single-Center Trial of Topical Cerdulatinib (DMVT-502) in Patients with Mild-to-Moderate Atopic Dermatitis
Stephen C. Piscitelli, Ana B. Pavel, Kimberly McHale, John E Jett, Jon Collins, Dawn Gillmor, Glenn Tabolt, Randall Li, Teresa Song, N. Zhang, Anna M. Tallman, Emma Guttman‐Yassky
Topics & Concepts
Atopic dermatitisSykMedicineDermatologySingle CenterRandomized controlled trialHyperkeratosisInternal medicineTyrosine kinaseReceptorDermatology and Skin DiseasesIL-33, ST2, and ILC PathwaysAsthma and respiratory diseases